ArticleMolecular cancer2014

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Claire Corcoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.